Detalhe da pesquisa
1.
The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors.
Anticancer Drugs
; 31(8): 799-805, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304410
2.
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology.
Glob Chall
; 7(10): 2300088, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37829677
3.
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.
Vaccines (Basel)
; 11(10)2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896984
4.
Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens.
Membranes (Basel)
; 13(11)2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999368
5.
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles.
Cancers (Basel)
; 15(13)2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444437
6.
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.
Res Sq
; 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292970
7.
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Vaccines (Basel)
; 11(10)2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896949
8.
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104101
9.
A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis.
Mol Cancer Ther
; 20(5): 859-871, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632875
10.
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform.
J Extracell Vesicles
; 10(4): e12066, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643549
11.
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo.
Oncotarget
; 11(41): 3698-3711, 2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110477
12.
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo.
MAbs
; 12(1): 1836713, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33136526
13.
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models.
Front Oncol
; 8: 481, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30416985